March 28, 2017 12:43 PM ET


Company Overview of Dafra Pharma International Ltd.

Company Overview

Dafra Pharma International Ltd. identifies and develops treatments against malaria and other neglected tropical diseases. The company manufactures and markets malaria treatments, branded generics, and consumer healthcare products for African patients. Its products include artemisinin based combination therapies, amoxicilline and clavulanic acid, ibuprofen, ciprofloxacine, paracetamol, ferric ammonium citrate, anaeban, dafravit, fortaline, amifer, pico, sania, and kinazol. The company caters to patients, prescribers, health professionals, hospitals, and government agencies. Dafra Pharma was incorporated in 1996 and is based in Turnhout, Belgium.

Slachthuisstraat 30/7

Turnhout,  2300


Founded in 1996


32 1 461 78 20


32 1 461 78 59

Key Executives for Dafra Pharma International Ltd.

Chief Executive Officer and Director
Medical Director
Administrative Director
French African Sales Director
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
Amakem NV Europe
Aminolabs SA Europe
Apotheek Delestre NV Europe
Apotheek Moons NV Europe
Apotheek Philips NV Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dafra Pharma International Ltd., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at